Close Menu

NEW YORK (GenomeWeb) – Fluidigm reported after the close of the market on Thursday that its first quarter revenues grew 19 percent year over year on strong demand for the company's Helios and Hyperion imaging mass cytometry systems.

For the three months ended March 31, 2019, Fluidigm tallied $30.1 million in revenues, up from $25.3 million a year ago and besting analysts' consensus estimate of $29.2 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers have developed a robotic lab assistant, the Verge reports.

CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.

The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.

In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.